PBSC

BIOLOGICAL5 trials

Sponsors

National Cancer Institute (NCI), Cancer and Leukemia Group B, St. Jude Children's Research Hospital, Nanfang Hospital, Southern Medical University

Conditions

Delayed Platelet EngraftmentHematological DiseasesHodgkin's DiseaseLeukemiaLymphomaNeuroblastomaNon Hodgkin's LymphomaPoor Graft Function

Phase 2

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

CompletedNCT00001430

National Cancer Institute (NCI)Hodgkin's Disease, Non Hodgkin's Lymphoma

Start: 1995-02-28End: 2002-01-31Target: 49Updated: 2008-03-04

Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

CompletedNCT00006252

Cancer and Leukemia Group BLeukemia, Lymphoma

Start: 2001-02-28End: 2011-10-31Updated: 2016-07-18

Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma

TerminatedNCT00808899

St. Jude Children's Research HospitalNeuroblastoma

Start: 2008-12-31End: 2009-07-31Updated: 2017-05-30

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Nanfang Hospital, Southern Medical UniversityHematological Diseases, Poor Graft Function, Stem Cell Transplantation, Hematopoietic

Start: 2014-01-31End: 2017-01-31Target: 120Updated: 2014-03-11

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Nanfang Hospital, Southern Medical UniversityDelayed Platelet Engraftment, Hematological Diseases, Poor Graft Function +1

Start: 2014-09-30End: 2018-12-31Target: 120Updated: 2014-09-16